SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurocrine Biosciences (NBIX) -- Ignore unavailable to you. Want to Upgrade?

To: Robohogs who wrote (1619)6/25/2006 3:21:12 AM
From: zeta1961  Read Replies (1) | Respond to of 1834
 
Why doxepin? Because it's the only insomnia product I know of off the top of my head in Phase 3 testing..its safety has been long established and they got comparable if not better results than I..Is there anything else in P2/P3?..please let me know if there is..

PIN..yup..I got creeped out when I went over there to see his current crusade..I trust your knowing of the amnesia effect as I'm can only go by PR's at this point..even with clean safety, I don't know how increasing nightly sleep in moderate to severe chronic insomniacs by max 1 hour makes a blockbuster esp. when insurance companies are not willing to pay..

I dunno' Jon..Perhaps as a swing trade..during this crucial time, I don't trust this ceo to stand up to the plate for shareholders..

Elisabeth



To: Robohogs who wrote (1619)9/3/2006 7:00:28 PM
From: Rocky9  Read Replies (1) | Respond to of 1834
 
Re Pin -

I didn't follow ELN though its fall and rise. So I only know pin from his NBIX crusade (now on InvestorVillage). He seems to make a lot of assumptions that are hard to support. But it is clear that he has a HUGE following. It just seems that there is a whale more risk in NBIX now than he seems to acknowledge.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News